Table 1 Socio-demographic characteristics of patients with thyrotoxicosis at the endocrine clinic, ACSH from December, 2017 to June, 2018
From: Thyrotoxicosis and dilated cardiomyopathy in developing countries
Variables | Frequency (N = 200) | Percentage (95 % CI) | |
|---|---|---|---|
Sex | |||
Female | 178 | 89.0 (83.8–93.0) | |
Male | 22 | 11.0 (7.0-16.2) | |
Age (in years) | |||
18–40 | 83 | 41.5 (34.6–48.7) | |
41–60 | 80 | 40.0 (33.1–47.1) | |
> 60 | 37 | 18.5 (13.4–24.6) | |
Residence | |||
Urban | 100 | 50 (42.9–57.1) | |
Rural | 100 | 50 (42.9–57.1) | |
Educational status | |||
Higher education | 30 | 15.0 (10.4–20.7) | |
Secondary school | 25 | 12.5 (8.3–17.9) | |
Primary school | 18 | 9.0 (5.4–13.9) | |
Able to read and write | 10 | 5.0 (2.4-9.0) | |
Unable to read and write | 117 | 58.5 (51.3–65.4) | |
Income | |||
< 1000 ETB (< 20 USD) | 106 | 53.0 (45.8–60.1) | |
1000–3000 ETB (20–60 USD) | 46 | 23.0 (17.4–29.5) | |
> 3000 ETB (> 60 USD) | 48 | 24.0 (18.3–30.5) | |
Primary diagnosis | |||
Toxic multinodular goiter | 102 | 51.5 (44.3–58.6) | |
Toxic nodular goiter | 75 | 37.5 (30.8–44.6) | |
Graves’ disease | 18 | 9.0 (5.4–13.9) | |
Other | 5 | 2.5 (0.8–5.7) | |